Custom Solutions for Complex Needs

Leading with strategy, our RCO  (Research Consulting Organization) model offers custom solutions that deliver results. Our fit-for purpose global services span across the full product lifecycle.

MedTech solutions

From concept to market, our experts provide custom-tailored medical device & diagnostic solutions to help meet your goals with proven results.

 

Oncology CRO services

Our full-service capabilities ensure the development and execution of a meticulously
designed drug development strategy for your Oncology clinical research project.

 

Strategic Global Partners

Our deep domain expertise spans across the full product lifecycle. with a team of locally-based experts who bring a comprehensive portfolio of services to help solve complex challenges in a dynamic environment.

 

MedTech

Oncology CRO Services

Global Solutions

Custom Solutions for Complex Needs

Leading with strategy, our RCO  (Research Consulting Organization) model offers custom solutions that deliver results. Our fit-for purpose global services span across the full product lifecycle.

RCO

MedTech

Oncology CRO Services

Global Solutions

MedTech solutions

From concept to market, our experts provide custom-tailored medical device & diagnostic solutions to help meet your goals with proven results.

 

RCO

MedTech

Oncology CRO Services

Global Solutions

Oncology CRO services

Our full-service capabilities ensure the development and execution of a meticulously
designed drug development strategy for your Oncology clinical research project.

 

RCO

MedTech

Oncology CRO Services

Global Solutions

Strategic Global Partners

Our deep domain expertise spans across the full product lifecycle. with a team of locally-based experts who bring a comprehensive portfolio of services to help solve complex challenges in a dynamic environment.

 

RCO

MedTech

Oncology CRO Services

Global Solutions

Inspiring the Future of Life Sciences to Deliver a Better Tomorrow

Aligning with World Health Day, ProPharma has released a short documentary video demonstrating the value of our unique RCO model which strives to improve global health outcomes.

Watch the Video   →

Watch ProPharma's Global Health Campaign Segment (7:30)

Welcome to the future of research consulting.


Our scalable nature and agility allows each part of our business to invest, innovate, and continuously improve to provide the right solutions for our clients. We revolutionized the traditional model, creating an entirely new system that redefines what’s possible for you and your organization. Meet the Research Consulting Organization (RCO)

Custom Solutions for Complex Needs

Click on a segment to learn more about our services
Click to learn more about regulatory sciences services
Click to learn more about clinical research solutions
Click to learn more about quality & compliance services
Click to learn more about pharmacovigilance solutions
Click to learn more about medical information services
Click to learn more about r&d technology services

Explore Our Core Services

One size has never fit all. We’re here to offer a custom alternative that fits your unique needs. A+ solutions scaled to your size. Each of our dedicated service lines provides world-class critical consulting services that operate autonomously across regulatory, safety, technology, and operations, but can perform as an integrated whole. 

icon (3)

regulatory sciences

ProPharma is the world’s leading regulatory sciences consulting firm offering support across the full lifecycle for drugs, biologics, medical devices, and diagnostics. ProPharma offers pre- and post-approval support for FDA, EMA, and other national competent authorities.
icon (1)

clinical research solutions

ProPharma offers industry leading support through a global team of trusted experts for multi-phase clinical development and study execution focused on drugs, biologics, medical devices, and diagnostics.
icon (2)

quality & compliance

ProPharma is an industry leader in quality & compliance with decades of experience in pharma consulting and regulation. ProPharma successfully brings products to market through maintenance of quality and compliance standards and records.
icon (4)

pharmacovigilance solutions

ProPharma is an industry-leading organization comprised of pharmacovigilance experts, offering a full suite of pharmacovigilance solutions to ensure safety and consistency from clinical development through post-approval.
icon (5)

medical information

ProPharma provides comprehensive medical information services, including fully integrated 24/7/365 contact centers. Our highly qualified medical information specialists utilize market-leading technologies and innovation to help our clients deliver current and accurate information and improve patient health and safety.
icon (6)

R&D technology

Science and technology have become increasingly intertwined, and unique expertise is required to move your project through the development lifecycle to completion. ProPharma helps life science organizations achieve technology solutions that enable their products to get to market quickly and efficiently.

Empowering our partners to transform scientific breakthroughs to life-changing patient outcomes & therapies.

Our team of experts have decades of experience across a wide variety of therapeutic areas & specialties. We work as an extension of your team, bringing you immediate resources who will align with your needs, processes, and environment.

Therapeutic areas mobile image

We bring the same passion we have for patients and healthcare solutions to our employees.

 

News & Insights

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

December 23, 2024

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

Discover strategies for establishing a medical information function in JAPAC, overcoming diverse regulations, data privacy laws, and cultural nuances.

WHO Issues Guidance on Antibiotic Pollution Control

December 23, 2024

WHO Issues Guidance on Antibiotic Pollution Control

WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

December 18, 2024

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Award Arrow Next Award Arrow
Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

December 23, 2024

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

Discover strategies for establishing a medical information function in JAPAC, overcoming diverse regulations, data privacy laws, and cultural nuances.

WHO Issues Guidance on Antibiotic Pollution Control

December 23, 2024

WHO Issues Guidance on Antibiotic Pollution Control

WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

December 18, 2024

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow

Next ProPharma Event

Our team has a consistent pulse on industry changes, the evolving marketplace, and patient needs. We are excited to attend several events in 2023. We look forward to meeting you to share new insights, explore new perspectives, uncover unmet business needs, and continuing professional development.

The Future of Research Consulting is Here

We’ve revolutionized the traditional model and put our clients at the very center.